{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:27:39Z","timestamp":1760956059759,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.reprotox.2020.07.003","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T10:03:27Z","timestamp":1594548207000},"page":"202-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessing anti-estrogenic effects of AHR ligands in primary human and rat endometrial epithelial cells"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8396-5494","authenticated-orcid":false,"given":"AD","family":"van den Brand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PC","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MBM","family":"van Duursen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.reprotox.2020.07.003_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"\u201cHormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review,\u201d","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.reprotox.2020.07.003_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1293\/tox.2015-0026","article-title":"Predictive modes of action of pesticides in uterine adenocarcinoma development in rats","volume":"28","author":"Yoshida","year":"2015","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2407-9-330","article-title":"\u201cExpression of oestrogen receptors, ER\u03b1, ER\u03b2, and ER\u03b2 variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ER\u03b1,\u201d","volume":"9","author":"Collins","year":"2009","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.reprotox.2020.07.003_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM197901043000103","article-title":"\u201cEndometrial cancer and estrogen use \u2014 report of a large case-control study,\u201d","volume":"300","author":"Antunes","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsbmb.2013.05.001","article-title":"Menopausal hormone therapy and risk of endometrial Cancer,\u201d","volume":"142","author":"Brinton","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.fct.2015.03.023","article-title":"Tetrabromobisphenol A (TBBPA): possible modes of action of toxicity and carcinogenicity in rodents,\u201d","volume":"80","author":"Lai","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1293\/tox.19.57","article-title":"A new hypothesis for uterine carcinogenesis\u202f: a pathway driven by modulation of estrogen metabolism through cytochrome P450 induction in the rat liver","volume":"19","author":"Yoshida","year":"2006","journal-title":"J. Toxicol. Pathol."},{"issue":"7","key":"10.1016\/j.reprotox.2020.07.003_bib0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/tx034036r","article-title":"Inhibitory aryl hydrocarbon receptor-estrogen receptor \u03b1 cross-talk and mechanisms of action,\u201d","volume":"16","author":"Safe","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0045","first-page":"103","article-title":"\u201cOne TEF concept does not fit all: the case for human risk assessment of polychlorinated biphenyls,\u201d","volume":"1","author":"van Duursen","year":"2016","journal-title":"Curr. Opin. Toxicol."},{"issue":"1","key":"10.1016\/j.reprotox.2020.07.003_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr218","article-title":"Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor","volume":"124","author":"Denison","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0055","first-page":"3149","article-title":"\u201cCorrelation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-Tetrachlorodibenzo-p-dioxin,\u201d","volume":"53","author":"Gierthy","year":"1993","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.reprotox.2020.07.003_bib0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0041-008X(78)90075-3","article-title":"\u201cResults of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats,\u201d","volume":"46","author":"Kociba","year":"1978","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.reprotox.2020.07.003_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3835(94)90144-9","article-title":"\u201cInhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin,\u201d","volume":"82","author":"Holcomb","year":"1994","journal-title":"Cancer Lett."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105458","article-title":"\u201cPrimary endometrial 3D co-cultures: a comparison between human and rat endometrium,\u201d","volume":"194","author":"van den Brand","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.reprotox.2020.07.003_bib0075","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/BF02624188","article-title":"\u201cIndication of selective growth of human endometrial epithelial cells on extracellular matrix,\u201d","volume":"24","author":"Birkenfeld","year":"1988","journal-title":"Vitr. Cell. Dev. Biol."},{"issue":"6","key":"10.1016\/j.reprotox.2020.07.003_bib0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1507\/endocrj.46.765","article-title":"\u201cExpression of Ah receptor and dioxin-related genes in human uterine endometrium in women with or without endometriosis","volume":"46","author":"Igarashi","year":"1999","journal-title":"Endocr. J."},{"issue":"4","key":"10.1016\/j.reprotox.2020.07.003_bib0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0002-9378(00)70325-5","article-title":"Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues,\u201d","volume":"182","author":"Bulun","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.reprotox.2020.07.003_bib0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00204-014-1261-3","article-title":"\u201cProgesterone, as well as 17b-estradiol, is important for regulating AHR battery homoeostasis in the rat uterus,\u201d","volume":"89","author":"Rataj","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"10","key":"10.1016\/j.reprotox.2020.07.003_bib0095","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00204-012-0870-y","article-title":"\u201cRegulation of uterine AHR battery gene expression by 17\u03b2-Estradiol is predominantly mediated by estrogen receptor a,\u201d","volume":"86","author":"Rataj","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2020.07.003_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0009-2797(99)00157-X","article-title":"Estrous cycle-dependent changes in the expression of aromatic hydrocarbon receptor (AHR) and AHR-nuclear translocator (ARNT) mRNAs in the rat ovary and liver,\u201d","volume":"124","author":"Chaffin","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0105","first-page":"63","article-title":"AHR ligands: promoscuity in binding and diversity in response","author":"DeGroot","year":"2012","journal-title":"AH Receptor Biol. Toxicol."},{"issue":"2692","key":"10.1016\/j.reprotox.2020.07.003_bib0110","article-title":"Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist","volume":"19","author":"Faber","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.reprotox.2020.07.003_bib0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/1541-7786.MCR-05-0101","article-title":"Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention,\u201d","volume":"4","author":"Sissung","year":"2006","journal-title":"Mol. Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.reprotox.2020.07.003_bib0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0303-7207(03)00079-0","article-title":"CYP1B1 gene in endometrial cancer,\u201d","volume":"202","author":"Sasaki","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tox.2019.04.009","article-title":"\u201cAnti-tumor properties of methoxylated analogues of resveratrol in malignant MCF-7 but not in non-tumorigenic MCF-10A mammary epithelial cell lines,\u201d","volume":"422","author":"van den Brand","year":"2019","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.reprotox.2020.07.003_bib0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0041-008X(03)00166-2","article-title":"\u201cEffects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines,\u201d","volume":"190","author":"van Duursen","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"February","key":"10.1016\/j.reprotox.2020.07.003_bib0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/toxsci\/71.1.20","article-title":"Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), of CYP1A1 and CYP1B1 in human lymphocytes,\u201d","volume":"71","author":"Lin","year":"2003","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2020.07.003_bib0140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/toxsci\/kfi089","article-title":"\u201cCytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility,\u201d","volume":"85","author":"van Duursen","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.reprotox.2020.07.003_bib0145","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/carcin\/21.8.1593","article-title":"Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17\u03b2-estradiol in female Sprague\u2013Dawley rats","volume":"21","author":"Badawi","year":"2002","journal-title":"Carcinogenesis"},{"issue":"3\u20135","key":"10.1016\/j.reprotox.2020.07.003_bib0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jsbmb.2011.03.008","article-title":"Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer,\u201d","volume":"125","author":"Cavalieri","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.jncimonographs.a024247","article-title":"Estrogens as endogenous genotoxic agents--DNA adducts and mutations","volume":"27","author":"Cavalieri","year":"2000","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"10.1016\/j.reprotox.2020.07.003_bib0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2217\/fon.09.137","article-title":"Depurinating estrogen\u2013DNA adducts in the etiology and prevention of breast and other human cancers,\u201d","volume":"6","author":"Cavalieri","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2017.03.007","article-title":"Potential role of CYP1B1 in the development and treatment of metabolic diseases,\u201d","volume":"178","author":"Li","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.reprotox.2020.07.003_bib0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1196\/annals.1386.042","article-title":"Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture,\u201d","volume":"1089","author":"Cavalieri","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/j.reprotox.2020.07.003_bib0175","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1158\/1055-9965.1515.13.9","article-title":"\u201cCytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk,\u201d","volume":"13","author":"Rylander-Rudqvist","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.reprotox.2020.07.003_bib0180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2002-020946","article-title":"\u201cCyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium,\u201d","volume":"88","author":"Shiozawa","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.reprotox.2020.07.003_bib0185","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/cncr.11760","article-title":"\u201cExpression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and ki-67 expression,\u201d","volume":"98","author":"Uchikawa","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.reprotox.2020.07.003_bib0190","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ijc.28741","article-title":"17b-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo,\u201d","volume":"135","author":"Laviolette","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"44","key":"10.1016\/j.reprotox.2020.07.003_bib0195","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1038\/s41388-018-0377-y","article-title":"GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer","volume":"37","author":"Hodgkinson","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.reprotox.2020.07.003_bib0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/toxsci\/62.1.46","article-title":"\u201cIn utero and lactational treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs mammary gland differentiation but does not block the response to exogenous estrogen in the postpubertal female rat,\u201d","volume":"62","author":"Lewis","year":"2001","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2020.07.003_bib0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1095\/biolreprod55.1.62","article-title":"\u201cIn utero and lactational exposure of female Holtzman rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin: modulation of the estrogen signal,\u201d","volume":"55","author":"Chaffin","year":"1996","journal-title":"Biol. Reprod."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623820301775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623820301775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:55:59Z","timestamp":1760190959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623820301775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"alternative-id":["S0890623820301775"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2020.07.003","relation":{},"ISSN":["0890-6238"],"issn-type":[{"type":"print","value":"0890-6238"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing anti-estrogenic effects of AHR ligands in primary human and rat endometrial epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2020.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}